Moderate to Severe Crohn's Disease
3 clinical trials · Condition
◉ Watch Moderate to Severe Crohn's Disease
| Record | Firm | Date |
|---|---|---|
| Rapidity of Response to Adalimumab Treatment in Patients With Crohn´s Disease (NCT02148718) | AbbVie | 2014-06-01 |
| NI-0401 in Active Crohn's Disease (NCT00630643) | Light Chain Bioscience - Novimmune SA | 2006-01-01 |
Track Moderate to Severe Crohn's Disease automatically
Every clearance here is in the API, with alerts when new ones post.